Anavex Life Sciences Corp (AVXL)

[XenaLives]

Compiled Due Diligence 09/29/19 & more ********

See this link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418975


******* Possible meetings for data presentation *******

October 28-29, 2020 9.00-17.30 EDT | Virtual Event
The inaugural Protein Misfolding Drug Discovery Digital Summit
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159044103

November 04, 2020 - November 07, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942181

Friday, November 6 Confirmed late breaking presentaton:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068231

November 16-17, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158943623

November 17, 2020[/b
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158968868

December 09-10, 2020
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158931494

**********************************************************************

Updated Pipeline
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068807

Biology concepts for Alzheimer’s disease (2/20 update)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158531542

Covid and Anavex:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068746
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159069029

Updated Trials
INSTRUCIONS TO VIEW UPDATES - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159068404
PDD - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067462
RETT AVATAR - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067552
RETT - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067617
EARLY ALZHEIMER'S - https://investorshub.advfn.com/boards/read_msg.aspx?message_id=159067667

New Parkinson’s news article re our positive PD Dementia trial results (from polarbear77)
https://parkinsonsnewstoday.com/2020/10/19/anavex-2-73-safe-aids-cognitive-skills-parkinsons-dementia-patients-phase-2-trial/

Actigraph will give objective sleep data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158938705

The slide that mentions Actigraphy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158955971

More comments on Actigraphy
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=157152758

Sleep - a few of many papers released within the last year:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158942413

PubChem reference for 2-73
https://pubchem.ncbi.nlm.nih.gov/compound/Anavex-2-73#section=Chemical-Disease-Co-Occurrences-in-Literature
see also this post on pubchem info:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822687

A new study finds new ways of detecting early, asymptomatic Alzheimer's disease (from falconer66):
https://www.eurekalert.org/pub_releases/2020-10/wsu-rdm101920.php

Effect of Peroxynitrite:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158822263

Autism and Mitochondrial Dysfunction:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964035
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158964348


TGA requirements have been discussed for years here.
OLE's may be as valuable as a trial for the purpose of Provisional approval.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158539684

ER–mitochondria signaling in Parkinson’s disease (from mapman's link to article post below)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=142355746&txt2find=autophagy
PDF of the article cited:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832754/pdf/41419_2017_Article_79.pdf
From "Compiled: MOA and MEDICAL SCIENCE DISCUSSION 09/29/19" at the following link:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=151418911

ALS and gut bacteria linked in “remarkable” new Harvard study (from georjejjl)
https://newatlas.com/science/als-gut-bacteria-microbiome-harvard-study/
https://www.anavex.com/wp-content/uploads/2019/12/CTAD2019_ANAVEX2-73_P84_Microbiota_.pdf

From MS Today and tradeherpete “Sigma-1 receptor agonists as potential protective therapies in multiple sclerosis”:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=155546193

Aarsland has been busy:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158700775

Biostockclub holds forth :)
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158688526

Basic info on PDD from nidan:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158724733

Air pollution particles in young brains linked to Alzheimer's damage
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158774113

Faster drug approval coming world wide:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158796012

Ransomware attack possible reason for delay in PDD trial data:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158710802
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158748463
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158797284

The key lies in being able to accelerate the rate of failure.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158828376

August 15, 2020 Media report on Rett Syndrome trial in Australia.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158829938

COGNITION IN PARKINSON'S
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158855354

Anavex 2-73 made with the SCF, supercritical fluid, for increased bioavaliability.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158825826

From JF comm. 10/08/20, w/ interesting PD comments and future---something about news in October:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158790564

Some of the scientific resources that MJFF utilizes, coordinates and makes available...
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897015
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=158897404